State-of-the-Art GMP Manufacturing RNA Cell Therapies with Cartesian's CEO

Cell & Gene: The Podcast

English - August 19, 2021 09:00 - 25 minutes - 17.8 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Therapeutic Firsts and "Eds and Meds" with Penn’s Dr. Bruce Levine

Next Episode: Chronic Lymphocytic Leukemia: A Patient's Perspective

We love to hear from our listeners. Send us a message.

Dr. Murat Kalayoglu, CEO at Cartesian Therapeutics, details the cell and gene therapy sector’s advancements in RNA cell therapy and the why behind the company's decision to build its own wholly-owned GMP manufacturing facility.